Search research articles
Contact Us
Filters
Showing results (161-170 of 248) with videos related to
Page
of 25
Sort By:
Steroids
|
March 1, 1972
Effect of 15-azasteroid analogues on cell culture growth
M L Higgins, R W Chesnut, F R Leach, et al.
Life Sciences
|
March 23, 2001
Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes
L Virág, T Fazekas, N Iost, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships
D M Benbrook, S Subramanian, J B Gale, et al.
Clinical Colorectal Cancer
|
June 19, 2013
Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing
Allison M Cushman-Vokoun, Daniel G Stover, Zhiguo Zhao, et al.
Gastrointestinal Cancer Research : GCR
|
October 19, 2012
A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer
A Bapsi Chakravarthy, Chiao Jillian Tsai, Nathan O'Brien, et al.
European Journal of Clinical Investigation
|
September 27, 2003
Clonidine improves postprandial baroreflex control in familial dysautonomia
H Marthol, M Tutaj, M Brys, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history
Bert H O'Neil, Robert Allen, David R Spigel, et al.
Neurology
|
February 10, 2010
Intracerebral and subarachnoid hemorrhage in patients with cancer
B B Navi, J S Reichman, D Berlin, et al.
American Journal of Clinical Oncology
|
April 16, 1998
5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889)
J D Berlin, K J Propert, D Trump, et al.
American Journal of Clinical Oncology
|
October 8, 2008
A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignancies
Laura W Goff, Mace L Rothenberg, A Craig Lockhart, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 248) with videos related to
Sort By:
Page
of 25
Steroids
|
March 1, 1972
Effect of 15-azasteroid analogues on cell culture growth
M L Higgins, R W Chesnut, F R Leach, et al.
Life Sciences
|
March 23, 2001
Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes
L Virág, T Fazekas, N Iost, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships
D M Benbrook, S Subramanian, J B Gale, et al.
Clinical Colorectal Cancer
|
June 19, 2013
Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing
Allison M Cushman-Vokoun, Daniel G Stover, Zhiguo Zhao, et al.
Gastrointestinal Cancer Research : GCR
|
October 19, 2012
A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer
A Bapsi Chakravarthy, Chiao Jillian Tsai, Nathan O'Brien, et al.
European Journal of Clinical Investigation
|
September 27, 2003
Clonidine improves postprandial baroreflex control in familial dysautonomia
H Marthol, M Tutaj, M Brys, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history
Bert H O'Neil, Robert Allen, David R Spigel, et al.
Neurology
|
February 10, 2010
Intracerebral and subarachnoid hemorrhage in patients with cancer
B B Navi, J S Reichman, D Berlin, et al.
American Journal of Clinical Oncology
|
April 16, 1998
5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889)
J D Berlin, K J Propert, D Trump, et al.
American Journal of Clinical Oncology
|
October 8, 2008
A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignancies
Laura W Goff, Mace L Rothenberg, A Craig Lockhart, et al.
Page
of 25